Stem cell transplantation for type 1 diabetes mellitus
Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
---|---|
Data(s) |
26/08/2013
26/08/2013
2009
|
Resumo |
Abstract Background The use of stem cells to treat type 1 diabetes mellitus has been proposed for many years, both to downregulate the immune system and to provide β cell regeneration. Conclusion High dose immunosuppression followed by autologous hematopoietic stem cell transplantation is able to induce complete remission (insulin independence) in most patients with early onset type 1 diabetes mellitus. |
Identificador |
http://www.producao.usp.br/handle/BDPI/33189 10.1186/1758-5996-1-4 |
Idioma(s) |
eng |
Relação |
Diabetology & Metabolic Syndrome |
Direitos |
openAccess Voltarelli and Couri; licensee BioMed Central Ltd. - This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
Tipo |
article original article |